Stockscreener 앱 받기
0.72
4.80%
0.033
전일 마감가:
$0.687
열려 있는:
$0.6716
하루 거래량:
146.67K
Relative Volume:
0.12
시가총액:
$7.56M
수익:
$19.98M
순이익/손실:
$-2.66M
주가수익비율:
-1.7617
EPS:
-0.4087
순현금흐름:
$-2.65M
1주 성능:
+3.15%
1개월 성능:
-6.49%
6개월 성능:
-62.69%
1년 성능:
-14.08%
1일 변동 폭
$0.67
$0.72
1주일 범위
$0.66
$0.72
52주 변동 폭
$0.4701
$2.56
cbdMD Inc Stock (YCBD) Company Profile
명칭
cbdMD Inc
전화
704-445-5800
주소
4521 Sharon Road, Charlotte, NC
Compare YCBD vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.72 | 7.56M | 19.98M | -2.66M | -2.65M | -0.4087 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
cbdMD Inc 주식(YCBD)의 최신 뉴스
cbdMD Inc (YCBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
cbdMD Inc (YCBD) Valuation: PE, PB & Fair Value Analysis - TradingKey
cbdMD Inc (YCBD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
cbdMD Inc (YCBD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
cbdMD Inc (YCBD) Institutional Confidence - TradingKey
cbdMD Promotes Wade Brown to Chief Marketing Officer as Multi-Brand Wellness Strategy Expands - citybiz
cbdMD appoints Wade Brown as Chief Marketing Officer - TipRanks
cbdMD appoints Wade Brown as chief marketing officer - Investing.com
CBD maker cbdMD hires growth veteran to expand on Amazon and beyond - Stock Titan
cbdMD Appoints Wade Brown Chief Marketing Officer - Yahoo Finance
cbdMD Inc. (YCBD) Slides Further as It Tests Key Support LevelWatchlist Stock Ideas - newsline.com
cbdMD Inc. (YCBD) Dips 2% – Support Level Holds Key to ReversalIV Percentile - newsline.com
cbdMD Inc. (YCBD) Edges Higher Amid Tight Trading Range – Key Levels in FocusAdaptive Moving Average - newsline.com
$cbdMD (YCBD.US)$ - Moomoo
cbdMD Inc. (YCBD) Slips 1.4% as Price Hovers Near Key SupportCorrective Wave - newsline.com
cbdMD (YCBD) Q1 2026 Earnings: EPS Misses Estimates as Company Faces HeadwindsQuarterly Financial Update - newsline.com
cbdMD Inc. (YCBD) Continues Slide, Testing Key Support at $0.68AAII Bullish - newsline.com
YCBD Q1 2026 Earnings: EPS Miss Highlights Continuing Operational ChallengesRevenue Estimate Trend - newsline.com
YCBD Q1 2026 Earnings: EPS Falls Short of Estimates Amid Continued Operational ChallengesCapex Guidance - newsline.com
cbdMD Inc. Q1 2026 Earnings: Significant EPS Miss Amid Ongoing Operational ChallengesEstimate Accuracy - newsline.com
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results - Insider Monkey
YCBD Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Call Highlights - newsline.com
cbdMD Inc. (YCBD) Surges 7.97% as Price Approaches Key ResistanceBPI Bear Correction - The Legal Advocate
YCBD Q1 2026 Earnings: EPS Misses Estimates as CBD Market Headwinds PersistEPS Consistency Score - thelegaladvocate.com
cbdMD Inc. (YCBD) Slips 2% as Stock Tests Key Support Near $0.70SuperTrend - The Legal Advocate
cbdMD Q1 2026 Earnings: EPS Misses Estimates Amid Challenging Market ConditionsEarnings Stability Report - newsline.com
cbdMD Inc. (YCBD) Q1 2026 Earnings: EPS Misses Estimates Amid Challenging Market ConditionsProfit Cycle Analysis - newsline.com
cbdMD extends Charlotte lease with reduced space and rent through 2031 - Investing.com Canada
cbdMD Amends Lease, Adjusts Long-Term Facility Commitments - TipRanks
cbdMD, Inc. (YCBD) Files 8-K Announcing Material Definitive Agreement and Financial Obligation – May 20, 2026 - Minichart
Lease change at cbdMD (NYSE: YCBD) cuts annual rent and shrinks footprint - Stock Titan
cbdMD Q1 earnings preview - MSN
Maxim Group Maintains CbdMD(YCBD.US) With Buy Rating, Maintains Target Price $2 - Moomoo
cbdMD, Inc. (AMEX:YCBD) Q3 2026 Earnings Call Transcript - Insider Monkey
cbdMD, Inc. (AMEX:YCBD) Q2 2026 Earnings Call Transcript - Insider Monkey
Cbdmd Inc Earnings Call: Growth Amid Margin Pressure - TipRanks
cbdMD Q2 2026 Loss Deepens: -$0.08/Share vs -$0.05 Expected - AlphaStreet
cbdMD Q2 2026 Deep Dive: EPS Misses by 60.0%, Revenue Up 19% - AlphaStreet
CbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript Summary - Moomoo
Earnings call transcript: cbdMD’s Q2 2026 sees revenue boost, margin dip By Investing.com - Investing.com South Africa
Earnings call transcript: cbdMD’s Q2 2026 sees revenue boost, margin dip - Investing.com UK
Transcript : CbdMD, Inc., Q2 2026 Earnings Call, May 14, 2026 - marketscreener.com
Full Transcript: cbdMD Q2 2026 Earnings Call - Benzinga
cbdMD reports 19% revenue growth in fiscal Q2 - Investing.com
cbdMD reports 19% revenue growth in fiscal Q2 By Investing.com - Investing.com Australia
CbdMD reports 19% year-over-year and 12% sequential revenue growth - marketscreener.com
CbdMD Reports 19% Year-Over-Year And 12% Sequential Revenue Growth - TradingView
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - Fidelity
Press Release: CbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - Moomoo
cbdMD (YCBD) grows revenue but warns on going concern and hemp rule risks - Stock Titan
cbdMD Inc (YCBD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
11.23%
0.45%
자본화:
|
볼륨(24시간):